Meitav Dash Investments Ltd. Buys 10,671 Shares of Danaher Co. (NYSE:DHR)

Meitav Dash Investments Ltd. raised its holdings in Danaher Co. (NYSE:DHRGet Rating) by 33.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,502 shares of the conglomerate’s stock after buying an additional 10,671 shares during the period. Meitav Dash Investments Ltd.’s holdings in Danaher were worth $12,383,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. GHP Investment Advisors Inc. bought a new stake in Danaher in the first quarter valued at approximately $26,000. Lloyd Advisory Services LLC. acquired a new position in shares of Danaher in the first quarter valued at approximately $26,000. Dixon Hughes Goodman Wealth Advisors LLC acquired a new position in shares of Danaher in the fourth quarter valued at approximately $29,000. Lee Financial Co acquired a new position in shares of Danaher in the fourth quarter valued at approximately $30,000. Finally, Evolution Advisers Inc. acquired a new position in shares of Danaher in the fourth quarter valued at approximately $32,000. Institutional investors own 78.42% of the company’s stock.

Danaher Trading Up 0.4 %

Shares of DHR stock opened at $290.00 on Friday. Danaher Co. has a fifty-two week low of $233.71 and a fifty-two week high of $333.96. The company has a market cap of $210.96 billion, a PE ratio of 34.16, a P/E/G ratio of 2.32 and a beta of 0.86. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.32 and a current ratio of 1.75. The stock’s fifty day moving average price is $261.98 and its two-hundred day moving average price is $268.32.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings results on Thursday, July 21st. The conglomerate reported $2.76 EPS for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. Danaher had a return on equity of 18.57% and a net margin of 20.61%. The company had revenue of $7.75 billion during the quarter, compared to analysts’ expectations of $7.29 billion. During the same period in the prior year, the company earned $2.46 EPS. Danaher’s revenue was up 7.4% compared to the same quarter last year. Equities analysts predict that Danaher Co. will post 10.39 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 29th. Stockholders of record on Friday, June 24th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date was Thursday, June 23rd. Danaher’s dividend payout ratio (DPR) is presently 11.78%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on DHR shares. KeyCorp decreased their target price on Danaher from $345.00 to $325.00 and set an “overweight” rating on the stock in a research report on Friday, July 22nd. UBS Group upped their target price on Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. Royal Bank of Canada raised Danaher from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $299.00 to $310.00 in a research report on Wednesday, June 1st. Wells Fargo & Company downgraded Danaher from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $330.00 to $265.00 in a research report on Monday, April 25th. Finally, Barclays increased their price target on Danaher from $290.00 to $310.00 in a research report on Friday, July 22nd. One investment analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher has an average rating of “Buy” and a consensus price target of $328.58.

Insider Transactions at Danaher

In other news, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, EVP Joakim Weidemanis sold 12,000 shares of Danaher stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $271.13, for a total value of $3,253,560.00. Following the completion of the transaction, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at approximately $20,171,529.74. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Walter G. Lohr sold 3,906 shares of the firm’s stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the completion of the sale, the director now owns 12,115 shares of the company’s stock, valued at $3,317,571.60. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company’s stock.

Danaher Company Profile

(Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRGet Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.